SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Cash flow Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2025-07-14			5-day change	1st Jan Change
11.05 ^CNY	+0.27%		+0.55%	-7.45%

07-01	Shyndec Pharmaceutical Unit Gets Registration Certificate for Hypertension Drug in China	MT
06-05	Shyndec Pharmaceutical's Two Drugs Pass Regulatory Evaluation	MT

7b8e97.xQKglGL8EQG7seBHD7BVwws0U0vUyCYr_8dzq79hSuA.8WbMuRude3PR9JYlRIEMl29aGw6ypXBoiKML3-o0K4O0dcn4FMxeRv6AsQ

Published financial data: SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	12.41B	13.76B	12.81B	11.79B	10.77B
Other Revenues, Total	148M	189M	150M	283M	168M
Total Revenues	12.56B	13.94B	12.96B	12.07B	10.94B
Cost of Goods Sold, Total	6.77B	7.91B	8.09B	7.54B	6.82B
Gross Profit	5.79B	6.04B	4.87B	4.53B	4.12B
Selling General & Admin Expenses, Total	4.05B	4.22B	3.41B	2.91B	1.92B
Provision for Bad Debts	26.24M	24.87M	-17.59M	-18.05M	-2.36M
R&D Expenses	494M	585M	517M	562M	566M
Other Operating Expenses	127M	128M	113M	115M	95.76M
Other Operating Expenses, Total	4.7B	4.96B	4.03B	3.57B	2.58B
Operating Income	1.09B	1.08B	841M	967M	1.54B
Interest Expense, Total	-124M	-110M	-107M	-57.88M	-36.89M
Interest And Investment Income	36.78M	48.84M	61.69M	136M	151M
Net Interest Expenses	-86.73M	-61.62M	-45.62M	78.59M	114M
Currency Exchange Gains (Loss)	-64.01M	-32.65M	98.32M	28.44M	40.61M
Other Non Operating Income (Expenses)	-9.6M	-5.75M	-4.23M	-4.09M	-2.01M
EBT, Excl. Unusual Items	935M	978M	890M	1.07B	1.69B
Impairment of Goodwill	-44.76M	-132M	-	-	-
Gain (Loss) On Sale Of Investments	-21.81M	-24.04M	-	-	-
Gain (Loss) On Sale Of Assets	21.15M	203K	-1.1M	-31.85M	-31.31M
Asset Writedown	-1.73M	-10.81M	-4.93M	-13.66M	-28.26M
Legal Settlements	-	-	-	-	-
Other Unusual Items	154M	107M	100M	71.77M	44.21M
EBT, Incl. Unusual Items	1.04B	918M	984M	1.1B	1.67B
Income Tax Expense	141M	97.06M	117M	132M	341M
Earnings From Continuing Operations	900M	821M	867M	965M	1.33B
Net Income to Company	900M	821M	867M	965M	1.33B
Minority Interest	-251M	-253M	-240M	-273M	-248M
Net Income - (IS)	649M	568M	628M	692M	1.08B
Net Income to Common Incl Extra Items	649M	568M	628M	692M	1.08B
Net Income to Common Excl. Extra Items	649M	568M	628M	692M	1.08B
Per Share Items
Net EPS - Basic	0.63	0.55	0.61	0.54	0.81
Basic EPS - Continuing Operations	0.63	0.55	0.61	0.54	0.81
Basic Weighted Average Shares Outstanding	1.03B	1.03B	1.03B	1.27B	1.34B
Net EPS - Diluted	0.55	0.48	0.54	0.54	0.81
Diluted EPS - Continuing Operations	0.55	0.48	0.54	0.54	0.81
Diluted Weighted Average Shares Outstanding	1.18B	1.18B	1.16B	1.27B	1.34B
Normalized Basic EPS	0.32	0.35	0.31	0.31	0.6
Normalized Diluted EPS	0.28	0.3	0.27	0.31	0.6
Dividend Per Share	0.1	0.1	0.1	0.1	0.3
Payout Ratio	32.42	37.39	29.42	27.37	27.75
Supplemental Items
EBITDA	1.82B	1.85B	1.67B	1.77B	2.29B
EBITA	1.12B	1.11B	874M	999M	1.57B
EBIT	1.09B	1.08B	841M	967M	1.54B
EBITDAR	1.86B	1.91B	1.69B	1.8B	2.31B
Total Revenues (As Reported)	12.56B	13.94B	12.96B	12.07B	10.94B
Effective Tax Rate - (Ratio)	13.55	10.57	11.85	12.03	20.38
Total Current Taxes	123M	125M	174M	143M	242M
Total Deferred Taxes	17.64M	-27.54M	-56.98M	-11.45M	98.61M
Normalized Net Income	333M	358M	316M	396M	807M
Interest Capitalized	35.42M	38.56M	29.27M	-	-
Interest on Long-Term Debt	94.43M	67.73M	-	-	2.97M
Non-Cash Pension Expense	-203K	421K	-32.79K	224K	15.4K
Supplemental Operating Expense Items
Advertising Expense	6.43M	7.1M	3.29M	4.64M	6.18M
Marketing Expenses	1.31M	-	-	-	-
Selling and Marketing Expenses	3.39B	3.48B	2.74B	2.15B	1.15B
General and Administrative Expenses	630M	722M	652M	744M	766M
Research And Development Expense From Footnotes	511M	603M	539M	586M	598M
Net Rental Expense, Total	45.13M	56.59M	28.89M	29.52M	25.77M
Imputed Operating Lease Interest Expense	13.54M	16.89M	8.32M	6.01M	6.66M
Imputed Operating Lease Depreciation	31.59M	39.69M	20.57M	23.51M	19.1M
Maintenance & Repair Expenses, Total	89.96M	18.5M	19.71M	25M	34.46M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.72B	4.28B	6.15B	5.97B	6.21B
Short Term Investments	-	-	-	-	1.43B
Total Cash And Short Term Investments	3.72B	4.28B	6.15B	5.97B	7.64B
Accounts Receivable, Total	2.6B	3.05B	2.66B	2.05B	1.36B
Other Receivables	108M	96.91M	92.85M	84.07M	85.55M
Notes Receivable	-	-	-	-	-
Total Receivables	2.71B	3.14B	2.75B	2.13B	1.45B
Inventory	3.28B	3.07B	2.44B	2.28B	2.21B
Prepaid Expenses	54.95M	40.21M	47.69M	61.63M	70.29M
Other Current Assets, Total	397M	345M	300M	207M	315M
Total Current Assets	10.16B	10.89B	11.68B	10.66B	11.68B
Gross Property Plant And Equipment	11.72B	12.52B	12.88B	13.05B	13.19B
Accumulated Depreciation	-5.31B	-6.01B	-6.63B	-7.17B	-7.64B
Net Property Plant And Equipment	6.41B	6.51B	6.25B	5.88B	5.55B
Long-term Investments	382M	371M	376M	1.43B	1.32B
Goodwill	292M	160M	160M	160M	160M
Other Intangibles, Total	525M	549M	517M	511M	591M
Deferred Tax Assets Long-Term	115M	189M	239M	153M	103M
Deferred Charges Long-Term	170M	145M	228M	332M	334M
Other Long-Term Assets, Total	195M	259M	179M	224M	217M
Total Assets	18.25B	19.07B	19.63B	19.35B	19.96B
Liabilities
Accounts Payable, Total	2.1B	1.54B	1.25B	1.37B	1.1B
Accrued Expenses, Total	440M	480M	1.67B	1.59B	1.42B
Short-term Borrowings	1.62B	2.01B	321M	45.05M	50.05M
Current Portion of Long-Term Debt	100M	540M	48.37M	-	1.03B
Current Portion of Leases	94.26M	40.13M	9.86M	10.6M	8.86M
Current Income Taxes Payable	23.84M	30.86M	37.94M	29.95M	72.51M
Unearned Revenue Current, Total	280M	1.4B	344M	245M	193M
Other Current Liabilities	1.53B	794M	510M	481M	465M
Total Current Liabilities	6.19B	6.84B	4.2B	3.78B	4.34B
Long-Term Debt	1.99B	1.55B	2.96B	1.03B	-
Long-Term Leases	590K	43M	68.57M	57.97M	47.94M
Unearned Revenue Non Current	167M	140M	138M	123M	114M
Pension & Other Post Retirement Benefits	685K	842K	571K	518K	364K
Deferred Tax Liability Non Current	80.31M	126M	120M	22.15M	70.77M
Other Non Current Liabilities	-	-	-	-	56.96M
Total Liabilities	8.43B	8.7B	7.48B	5.01B	4.63B
Common Stock, Total	1.03B	1.03B	1.17B	1.34B	1.34B
Additional Paid In Capital	2.55B	2.55B	3.59B	5.2B	5.2B
Retained Earnings	4.3B	4.76B	5.29B	5.84B	6.66B
Comprehensive Income and Other	259M	259M	259M	-1.09M	-911K
Total Common Equity	8.13B	8.59B	10.31B	12.39B	13.2B
Minority Interest	1.69B	1.78B	1.85B	1.95B	2.12B
Total Equity	9.82B	10.37B	12.15B	14.34B	15.32B
Total Liabilities And Equity	18.25B	19.07B	19.63B	19.35B	19.96B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.03B	1.03B	1.17B	1.34B	1.34B
ECS Total Common Shares Outstanding	1.03B	1.03B	1.17B	1.34B	1.34B
Book Value / Share	7.92	8.37	8.57	9.24	9.85
Tangible Book Value	7.31B	7.88B	9.63B	11.72B	12.45B
Tangible Book Value Per Share	7.12	7.68	7.99	8.74	9.28
Total Debt	3.81B	4.18B	3.4B	1.14B	1.14B
Net Debt	86.79M	-99.84M	-2.74B	-4.83B	-6.51B
Debt Equivalent of Unfunded Proj. Benefit Obligation	823K	1.07M	807K	782K	472K
Debt Equivalent Oper. Leases	361M	453M	231M	236M	206M
Minority Interest, Total (Incl. Fin. Div)	1.69B	1.78B	1.85B	1.95B	2.12B
Equity Method Investments, Total	155M	145M	150M	156M	169M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.12B	1.06B	864M	708M	632M
Inventories - Work In Process, Total	500M	544M	556M	481M	400M
Inventories - Finished Goods, Total	1.64B	1.45B	1.02B	1.08B	1.19B
Inventories - Others	74.55M	86.38M	81.24M	85.04M	66.22M
Buildings, Total	3.71B	3.87B	3.94B	4.47B	4.49B
Machinery, Total	6.89B	7.92B	8.18B	8.37B	8.45B
Full Time Employees	12.95K	11.94K	11.49K	11.61K	11.47K
Assets under Capital Lease - Gross	533M	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-357M	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	78.03M	101M	86.54M	68.16M	59.48M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	649M	568M	628M	692M	1.08B
Depreciation & Amortization - CF	696M	786M	804M	782M	728M
Amortization of Goodwill and Intangible Assets - (CF)	27.77M	29.31M	32.4M	31.32M	38.25M
Depreciation & Amortization, Total	723M	815M	837M	813M	766M
Amortization of Deferred Charges, Total - (CF)	13.28M	15.83M	11.98M	12.33M	12.07M
(Gain) Loss From Sale Of Asset	-23.92M	-203K	1.1M	31.85M	31.31M
(Gain) Loss on Sale of Investments - (CF)	21.81M	24.04M	-2.34M	-27.45M	-64.11M
Asset Writedown & Restructuring Costs	47.53M	136M	3.43M	13.13M	28.26M
Provision and Write-off of Bad Debts	26.24M	24.87M	-17.59M	-18.05M	-2.36M
Other Operating Activities, Total	405M	406M	394M	399M	427M
Change In Accounts Receivable	-993M	-921M	463M	485M	733M
Change In Inventories	-967M	195M	625M	163M	60.54M
Change In Accounts Payable	1.65B	444M	-30.39M	-833M	-919M
Change In Deferred Taxes	5.99M	-27.54M	-56.98M	-11.45M	98.61M
Cash from Operations	1.56B	1.68B	2.86B	1.72B	2.26B
Capital Expenditure	-378M	-521M	-307M	-357M	-220M
Sale of Property, Plant, and Equipment	26.02M	3.72M	5M	10.96M	21.95M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-208M	1.14M	-	2.01M	3M
Other Investing Activities, Total	2.68M	8.31M	-	-1.02B	-661M
Cash from Investing	-557M	-508M	-302M	-1.36B	-856M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	3.3B	3.69B	2.35B	45M	50M
Total Debt Issued	3.3B	3.69B	2.35B	45M	50M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-4.08B	-3.4B	-3.19B	-774M	-61.44M
Total Debt Repaid	-4.08B	-3.4B	-3.19B	-774M	-61.44M
Issuance of Common Stock	-	-	1.19B	-	-
Common Dividends Paid	-210M	-212M	-185M	-189M	-301M
Common & Preferred Stock Dividends Paid	-210M	-212M	-185M	-189M	-301M
Other Financing Activities, Total	-981M	-733M	-594M	-175M	-103M
Cash from Financing	-1.97B	-662M	-435M	-1.09B	-415M
Foreign Exchange Rate Adjustments	-44.35M	-40.08M	94.24M	32.07M	29.63M
Net Change in Cash	-1.01B	469M	2.21B	-704M	1.01B
Supplemental Items
Cash Income Tax Paid (Refund)	702M	696M	618M	752M	693M
Levered Free Cash Flow	-101M	622M	1.63B	1.8B	1.67B
Unlevered Free Cash Flow	-23.84M	691M	1.7B	1.83B	1.69B
Change In Net Working Capital	1.07B	292M	-634M	-760M	-173M
Net Debt Issued / Repaid	-774M	283M	-845M	-729M	-11.44M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.81	3.61	2.72	3.1	4.88
Return on Total Capital	4.98	4.78	3.49	3.9	6.01
Return On Equity %	9.46	8.13	7.7	7.28	8.98
Return on Common Equity	8.26	6.8	6.64	6.1	8.47
Margin Analysis
Gross Profit Margin %	46.12	43.28	37.57	37.55	37.63
SG&A Margin	32.24	30.26	26.35	24.07	17.56
EBITDA Margin %	14.48	13.28	12.85	14.63	20.92
EBITA Margin %	8.94	7.94	6.74	8.27	14.39
EBIT Margin %	8.72	7.73	6.49	8.01	14.04
Income From Continuing Operations Margin %	7.17	5.89	6.69	7.99	12.18
Net Income Margin %	5.17	4.08	4.84	5.73	9.91
Net Avail. For Common Margin %	5.17	4.08	4.84	5.73	9.91
Normalized Net Income Margin	2.65	2.57	2.44	3.28	7.38
Levered Free Cash Flow Margin	-0.8	4.46	12.61	14.88	15.25
Unlevered Free Cash Flow Margin	-0.19	4.95	13.12	15.18	15.46
Asset Turnover
Asset Turnover	0.7	0.75	0.67	0.62	0.56
Fixed Assets Turnover	1.98	2.16	2.03	1.99	1.91
Receivables Turnover (Average Receivables)	5.68	4.87	4.49	5.01	6.31
Inventory Turnover (Average Inventory)	2.42	2.49	2.94	3.19	3.04
Short Term Liquidity
Current Ratio	1.64	1.59	2.78	2.82	2.69
Quick Ratio	1.04	1.09	2.12	2.15	2.09
Operating Cash Flow to Current Liabilities	0.25	0.25	0.68	0.46	0.52
Days Sales Outstanding (Average Receivables)	64.39	74.96	81.25	72.87	57.97
Days Outstanding Inventory (Average Inventory)	151.46	146.61	124.33	114.28	120.43
Average Days Payable Outstanding	82.25	86.43	68.31	64.89	67.15
Cash Conversion Cycle (Average Days)	133.61	135.13	137.28	122.27	111.25
Long Term Solvency
Total Debt/Equity	38.76	40.35	28	7.98	7.43
Total Debt / Total Capital	27.93	28.75	21.88	7.39	6.91
LT Debt/Equity	20.25	15.33	24.88	7.59	0.31
Long-Term Debt / Total Capital	14.6	10.93	19.44	7.03	0.29
Total Liabilities / Total Assets	46.2	45.62	38.09	25.91	23.22
EBIT / Interest Expense	8.86	9.76	7.84	16.71	41.63
EBITDA / Interest Expense	14.72	17.14	15.64	30.76	62.4
(EBITDA - Capex) / Interest Expense	11.66	12.42	12.77	24.58	56.44
Total Debt / EBITDA	2.09	2.21	2.03	0.64	0.49
Net Debt / EBITDA	0.05	-0.05	-1.64	-2.71	-2.83
Total Debt / (EBITDA - Capex)	2.64	3.05	2.48	0.8	0.55
Net Debt / (EBITDA - Capex)	0.06	-0.07	-2	-3.39	-3.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.93	11.06	-7.07	-6.86	-9.38
Gross Profit, 1 Yr. Growth %	-2.84	4.23	-19.34	-6.9	-9.19
EBITDA, 1 Yr. Growth %	-2.27	1.64	-10.3	5.66	28.07
EBITA, 1 Yr. Growth %	-4.67	-1.63	-21.48	13.54	56.66
EBIT, 1 Yr. Growth %	-3.8	-1.54	-21.96	14.99	58.75
Earnings From Cont. Operations, 1 Yr. Growth %	-3.06	-8.77	5.64	11.2	38.1
Net Income, 1 Yr. Growth %	-1.15	-12.41	10.47	10.21	56.62
Normalized Net Income, 1 Yr. Growth %	-7.63	7.67	-11.72	25.23	103.63
Diluted EPS Before Extra, 1 Yr. Growth %	-3.49	-12.29	12.52	0.07	48.72
Accounts Receivable, 1 Yr. Growth %	47.55	17.11	-12.86	-22.77	-33.64
Inventory, 1 Yr. Growth %	41.53	-6.36	-20.59	-6.53	-3.14
Net Property, Plant and Equip., 1 Yr. Growth %	2.58	1.59	-4.06	-5.79	-5.68
Total Assets, 1 Yr. Growth %	3.47	4.49	2.94	-1.42	3.12
Tangible Book Value, 1 Yr. Growth %	8.9	7.78	22.13	21.69	6.28
Common Equity, 1 Yr. Growth %	7.17	5.68	19.93	20.21	6.58
Cash From Operations, 1 Yr. Growth %	22.84	7.66	70.01	-39.76	31.13
Capital Expenditures, 1 Yr. Growth %	-6.4	37.96	-41.04	16.18	-38.47
Levered Free Cash Flow, 1 Yr. Growth %	-69.55	-744.08	162.68	9.96	-7.13
Unlevered Free Cash Flow, 1 Yr. Growth %	-88.83	-3.67K	146.14	7.75	-7.7
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	200
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.32	6.92	1.59	-6.97	-8.13
Gross Profit, 2 Yr. CAGR %	3.01	0.63	-8.31	-13.35	-8.05
EBITDA, 2 Yr. CAGR %	2.49	-0.25	-4.38	-2.47	17
EBITA, 2 Yr. CAGR %	4.23	-3.03	-11.9	-5.26	33.77
EBIT, 2 Yr. CAGR %	4.67	-2.68	-12.35	-5.27	35.11
Earnings From Cont. Operations, 2 Yr. CAGR %	-8.28	-5.96	-1.83	8.38	23.92
Net Income, 2 Yr. CAGR %	-4.1	-6.95	-1.63	10.34	31.38
Normalized Net Income, 2 Yr. CAGR %	-11.96	-0.27	-2.51	5.14	59.69
Diluted EPS Before Extra, 2 Yr. CAGR %	-7.73	-8	-0.66	6.11	22
Accounts Receivable, 2 Yr. CAGR %	22.62	31.45	1.02	-17.97	-28.41
Inventory, 2 Yr. CAGR %	19.05	15.12	-13.77	-13.85	-4.85
Net Property, Plant and Equip., 2 Yr. CAGR %	2.51	2.08	-1.28	-4.93	-5.74
Total Assets, 2 Yr. CAGR %	5.29	3.98	3.71	0.74	0.82
Tangible Book Value, 2 Yr. CAGR %	11.33	8.34	14.73	21.91	13.72
Common Equity, 2 Yr. CAGR %	9.3	6.42	12.58	20.07	13.19
Cash From Operations, 2 Yr. CAGR %	-3.32	15	35.29	1.2	-11.12
Capital Expenditures, 2 Yr. CAGR %	-2.72	13.63	-9.81	-17.23	-15.45
Levered Free Cash Flow, 2 Yr. CAGR %	-80.58	36.91	311.32	69.95	1.05
Unlevered Free Cash Flow, 2 Yr. CAGR %	-90.79	79.94	837.3	62.85	-0.28
Dividend Per Share, 2 Yr. CAGR %	0	0	0	0	73.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.81	7.2	2.04	-1.31	-7.78
Gross Profit, 3 Yr. CAGR %	16.88	3.42	-6.52	-7.84	-11.98
EBITDA, 3 Yr. CAGR %	-1.14	2.26	-3.63	-1.03	7.21
EBITA, 3 Yr. CAGR %	0.02	2.33	-9.48	-3.91	12.25
EBIT, 3 Yr. CAGR %	0.84	2.56	-9.58	-4.05	12.52
Earnings From Cont. Operations, 3 Yr. CAGR %	3.21	-8.45	-2.24	2.34	17.5
Net Income, 3 Yr. CAGR %	7.95	-6.96	-1.47	2.17	24
Normalized Net Income, 3 Yr. CAGR %	15.48	-5.85	-4.24	5.98	31.06
Diluted EPS Before Extra, 3 Yr. CAGR %	5.78	-9.27	-1.61	-0.41	18.75
Accounts Receivable, 3 Yr. CAGR %	9.23	20.76	14.62	-7.63	-23.56
Inventory, 3 Yr. CAGR %	19.59	9.89	1.72	-11.42	-10.42
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.69	2.2	-0.01	-2.8	-5.18
Total Assets, 3 Yr. CAGR %	6.35	5.02	3.63	1.97	1.52
Tangible Book Value, 3 Yr. CAGR %	12.58	10.14	12.75	17.01	16.46
Common Equity, 3 Yr. CAGR %	9.62	8.08	10.74	15.07	15.4
Cash From Operations, 3 Yr. CAGR %	-12.32	0.21	31	3.31	10.33
Capital Expenditures, 3 Yr. CAGR %	30.92	9.29	-8.69	-1.87	-25.02
Levered Free Cash Flow, 3 Yr. CAGR %	-57.65	-38.55	70.12	164.97	38.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	-74.8	-37.33	99.75	355.75	34.77
Dividend Per Share, 3 Yr. CAGR %	25.99	0	0	0	44.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.92	8.85	8.76	1.29	-2.16
Gross Profit, 5 Yr. CAGR %	13.56	13.44	6.06	-3.64	-7.14
EBITDA, 5 Yr. CAGR %	-1.39	-0.43	-2.42	0.4	4.22
EBITA, 5 Yr. CAGR %	-3.18	-2.06	-4.88	-0.68	5.97
EBIT, 5 Yr. CAGR %	-2.76	-1.58	-4.66	-0.65	6.17
Earnings From Cont. Operations, 5 Yr. CAGR %	0.22	-0.78	1.17	-2.05	7.49
Net Income, 5 Yr. CAGR %	4.13	3.57	4.01	-0.39	10.55
Normalized Net Income, 5 Yr. CAGR %	3.33	11.13	7.92	-1.6	17.49
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.36	2.34	3.16	-3.41	7.23
Accounts Receivable, 5 Yr. CAGR %	10.05	5	5.87	3.45	-5.05
Inventory, 5 Yr. CAGR %	11.03	11.17	4.92	-0.3	-0.96
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.89	-2.12	-1.52	-0.71	-2.34
Total Assets, 5 Yr. CAGR %	5.52	4.9	5.29	3.29	2.5
Tangible Book Value, 5 Yr. CAGR %	21.53	11.38	13.44	14.7	13.14
Common Equity, 5 Yr. CAGR %	15.95	8.54	10.79	12.73	11.72
Cash From Operations, 5 Yr. CAGR %	-1.3	14.9	4.29	0.61	12.18
Capital Expenditures, 5 Yr. CAGR %	-0.96	16.66	12.79	-2.21	-11.46
Levered Free Cash Flow, 5 Yr. CAGR %	-8.89	-2.21	4.19	-7.69	38.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-42.13	-4.67	2.69	-8.18	51.29
Dividend Per Share, 5 Yr. CAGR %	31.95	-5.11	14.87	0	24.57